PaxMedica CEO Interviewed by The BRAIN Foundation
20 juin 2023 08h30 HE
|
PaxMedica, Inc.
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on...
PaxMedica Completes HAT-301 Registrational Trial for PAX-101
01 juin 2023 08h00 HE
|
PaxMedica, Inc.
HAT-301 is the Pivotal Efficacy Study to Support Upcoming NDA Filing Top Line Results Planned for Release in July 2023 TARRYTOWN, NY, June 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Specialized Education Services, Inc. Grows Educational Offerings in Illinois With Acquisition of NewHope Academy
11 mai 2023 11h42 HE
|
Specialized Education Services, Inc.
PHILADELPHIA, May 11, 2023 (GLOBE NEWSWIRE) -- Specialized Education Services, Inc. (SESI) today announced the acquisition of NewHope Academy (NHA), a special education school in Arlington Heights,...
CentralReach’s Special Education Solution, LiftEd, and EMR Solution for Small Practices, CR Essentials, Honored as Winners of the 2023 American Business Awards®
28 avr. 2023 11h00 HE
|
CentralReach
FORT LAUDERDALE, Fla., April 28, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD care software, has been named a winner in two categories of the 21st Annual American...
Film, Art and Life Blends Together in “The Midway Point”
18 avr. 2023 14h36 HE
|
XpandMusic
LOS ANGELES, April 18, 2023 (GLOBE NEWSWIRE) -- The famous quote “Art imitates life” has never been more meaningful to what happens in the feature film “The Midway Point”. Written and directed by...
Researchers Discover a New Embryonic Brain Circuit
13 avr. 2023 10h54 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
EMBARGOED UNTIL 17-APR-2023 11:00 ET The findings may provide new insights into circuit abnormalities in autism. ...
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder (ASD)
04 avr. 2023 08h00 HE
|
Axial Therapeutics
-- Children aged 5 to 17 with autism are now eligible to enroll in the clinical trial of AB-2004, a gut targeted, molecular therapeutic -- -- Novel small molecule microbiome approach focused on...
Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics
29 mars 2023 08h00 HE
|
Axial Therapeutics
– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...
STEP Thrift Store and Donation Centers Implements CentralReach’s avail® Software Organization-Wide to Hire, Train, and Retain Neurodiverse Employees
28 mars 2023 10h00 HE
|
CentralReach
Fort Lauderdale, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of autism and IDD care software, today announced that Services To Enhance Potential (STEP) Thrift Store...
New Study: Brain Training Improve Clinical and Cognitive Measures in Autism
27 mars 2023 08h00 HE
|
Posit Science
SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- New results from a study of brain training among people with autism spectrum disorder (ASD) show significant gains in clinical and cognitive...